Clinical Effect of Integrated Chinese and Western Medicine in Treating Chronic Bronchitis and Complicated with Emphysema
DOI:
https://doi.org/10.54097/hset.v30i.5231Keywords:
Integrated Traditional Chinese and Western Medicine; Chronic Bronchitis; Emphysema; Clinical Effect Observation.Abstract
Chronic bronchitis is a chronic inflammatory disease caused by lung dysfunction caused by various causes. Clinically, the main manifestations are chronic cough, sputum cough and chest tightness and other symptoms, and accompanied by emphysema in patients with dyspnea, cough and asthma are more obvious. According to statistics, the prevalence rate of Chinese adults is 4.2%~6.4%. At present, the research on chronic bronchitis complicated with emphysema at home and abroad is still in the early stage or mainly in the acute attack stage, which is mostly related to the long-term use of non-steroidal anti-inflammatory drugs, surgical treatment and smoking. For patients with chronic bronchitis and emphysema, it is not feasible to use antibiotics alone, while TCM treatment can not only improve the symptoms but also improve the quality of life of the patients. This paper will summarize the clinical effect and prospects of Chinese and Western medicine in patients with chronic bronchitis and emphysema in recent years.
Downloads
References
Gong Chunyan. The influence of comprehensive care on sleep quality and negative mood in patients with chronic bronchitis and emphysema [J]. World Journal of Sleep Medicine, 2021,008 (001): 94-95.
Mei Cunhua, Zhang Dongxing, Ge Tengteng. Comparison of the effects of TCM syndrome differentiation therapy and Western medicine therapy on bronchitis complicated with emphysema [J]. Contemporary Medicine Theory cluster, 2020,18 (15): 2.
Li H J. Clinical observation on the treatment of chronic bronchitis combined with emphysema by Chinese and Western medicine [J]. New Chinese Medicine,2015,47(05):68-69.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.







